Patients with moderate to severe asthma saw increases in FEV1 within 24 hours after taking a loading dose of rademikibart, ...

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis and ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

The Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD ...

Imagine looking at thousands of scattered puzzle pieces and trying to guess what picture they create. Without any reference ...

By making these retinal pigment epithelium (RPE) cells visible, researchers have created implications for early detection of ...

In biology classes from high school through university, I learned that mitochondria are little objects that reside within ...

A team of scientists has answered a long-standing question in cell biology, uncovering how the cell's main energy currency, ATP, is transported into the endoplasmic reticulum (ER). Disrupted energy ...

A team of scientists has answered a long-standing question in cell biology, uncovering how the cell's main energy currency, ...

Rademikibart significantly improved airway function, as measured by FEV1, within a day and significantly reduced acute exacerbations in patients with inflammation-mediated chronic asthma strongly supp ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, presented 11 ...

This leads to varying sensitivity from the multiple cell types targeted within the lungs, and the resultant therapeutic efficacy depends not only on drug pharmacology but also on the extent, site and ...